What are the latest developments, and how are challenges in R&D, manufacturing, logistics and market access being tackled?

Discover from our experts the solutions to your biggest challenges and gain answers to your most pressing questions including:

• What clinical progress has been achieved in allogeneic therapies
• Whether CAR-T has a future in solid tumors
• How genetic engineering can enhance the efficacy of cell therapies in the tumor microenvironment
• How to scale up manufacturing for clinical and commercial production
• How to ensure patient access to these life-changing drugs